Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2-hour postprandial glucose, and 30 mg/dL (22%) for mean 24-hour glucose concentration (see Figure 1)
This works through the same eligibility criteria as the oral program
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus
We have a lot more to learn around this, and this story is not over, meaning we and our competitors will be revisiting it over time
doi:10.1210/jc.2006-1702 Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Peitra C
When these systems work well, you recover faster, protect your joints, and see better results from your training and diet, even as you age
